oxaliplatin
- Product NDC
- 68001-341
- 11-digit product format
- 680010341
- Labeler code
- 68001
- Product ID
- 68001-341_153be3f9-43ed-45ce-8099-6904ab729de7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- oxaliplatin
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- BluePoint Laboratories
- Application
- ANDA208523
- Marketing category
- ANDA
- Marketing start
- 2018-02-09
- Marketing end
- 0000-00-00
- Substance
- OXALIPLATIN
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Platinum-based Drug [EPC],Platinum-containing Compounds [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68001-341-36 | 68001034136 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-341-36) > 10 mL in 1 VIAL, SINGLE-DOSE (68001-341-28) | 2018-02-09 | 0000-00-00 | No | No | Current |
| 68001-341-37 | 68001034137 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-341-37) > 20 mL in 1 VIAL, SINGLE-DOSE (68001-341-29) | 2018-02-09 | 0000-00-00 | No | No | Current |